Does neuroprotection improve stroke outcome?

被引：46

作者：

Lees, KR ^{[1
]}

机构：

[1] Univ Glasgow, Western Infirm, Acute Stroke Unit, Glasgow G11 6NT, Lanark, Scotland

来源：

LANCET | 1998年 / 351卷 / 9114期

关键词：

D O I：

10.1016/S0140-6736(05)78865-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1447 / 1448

页数：2

共 18 条

[1]

Asplund K, 1997, BMJ-BRIT MED J, V314, P1151

[2]

Bath P, 1997, BRIT MED J, V315, P1167

[3]

CANDELISE L, 1995, LANCET, V346, P1509

[4] Termination of acute stroke studies involving selfotel treatment [J].

Davis, SM ;

Albers, GW ;

Diener, HC ;

Lees, KR ;

Norris, J .

LANCET, 1997, 349 (9044) :32-32

[5] Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke [J].

Diener, HC .

CEREBROVASCULAR DISEASES, 1998, 8 (03) :172-181

[6] Lubeluzole in acute ischemic stroke - A double-blind, placebo-controlled phase II trial [J].

Diener, HC ;

Hacke, W ;

Hennerici, M ;

Radberg, J ;

Hantson, L ;

DeKeyser, J .

STROKE, 1996, 27 (01) :76-81

[7]

DONNAN GA, 1995, LANCET, V345, P578

[8]

Dyker Alexander G., 1997, Stroke, V28, P233

[9] Lubeluzole treatment of acute ischemic stroke [J].

Grotta, J .

STROKE, 1997, 28 (12) :2338-2346

[10]

Hommel M, 1996, NEW ENGL J MED, V335, P145

← 1 2 →